Department of Health and Human Services July 1, 2024 – Federal Register Recent Federal Regulation Documents
Results 1 - 11 of 11
Request for Information (RFI): Inviting Comments and Suggestions on an ODS Strategic Plan 2025-2029: A Blueprint for a Coordinated Dietary Supplement Research Agenda at NIH
The National Institutes of Health (NIH), Office of Dietary Supplements (ODS) is continuing to use a structured planning process to develop its five-year strategic plans. After a new director joined ODS in July 2023 a new strategic plan for 2025-2029 was developed titled "A Blueprint for a Coordinated Dietary Supplement Research Agenda at NIH." ODS is committed to engaging its partners and other interested parties including representatives of the scientific community, industry, other federal agencies, policymakers, and the public in the strategic planning process by soliciting their comments on the draft ODS Strategic Plan for Fiscal Years (CY) 2025-2029.
Lists of Designated Primary Medical Care, Mental Health, and Dental Health Professional Shortage Areas
This notice informs the public of the availability of the complete lists of all geographic areas, population groups, and facilities designated as primary medical care, dental health, and mental health professional shortage areas (HPSAs) in a designated status as of April 15, 2024. The lists are available on the shortage area topic page on HRSA's data.hrsa.gov website. All currently designated HPSAs remain designated until final lists are published later this fall. HPSA designations that are currently proposed for withdrawal will remain in this status until the publication of the HPSA Federal Register notice on or before November 1, 2024. HPSAs proposed for withdraw will be re-evaluated before final publication if additional information is made available to HPSA by states. If these HPSAs do not meet the requirements for designation at the time of the publication of the HPSA Federal Register on or before November 1, 2024, they will be withdrawn.
Vessel Sanitation Program: Annual Program Status Meeting; Request for Comment
The Centers for Disease Control and Prevention (CDC) in the Department of Health and Human Services (HHS) announces the opening of a docket to obtain comment on the FY 2024 annual Vessel Sanitation Program (VSP) public meeting. The August 5, 2024, annual meeting is a forum for CDC to update cruise industry representatives and other interested persons on programmatic activities and future plans. CDC is opening a public docket for additional comments and materials. The official record of this meeting will remain open through August 30, 2024 so comments related to the discussion topics can be part of the record.
Agency Information Collection Activities: Proposed Collection; Comment Request
This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve a revision of the currently approved information collection project: "Medical Expenditures Panel SurveyHousehold and Medical Provider Components." This proposed information collection was previously published in the Federal Register on April 19, 2024 and allowed 60 days for public comment. No comments were received. The purpose of this notice is to allow an additional 30 days for public comment.
Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies
The Department of Health and Human Services (HHS) notifies Federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITFs) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines) using Urine and the laboratories currently certified to meet the standards of the Mandatory Guidelines using Oral Fluid.
Essential Drug Delivery Outputs for Devices Intended To Deliver Drugs and Biological Products; Draft Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Essential Drug Delivery Outputs for Devices Intended to Deliver Drugs and Biological Products." This guidance addresses key aspects of drug delivery performance information for devices, and combination products that include device constituent parts, intended for delivery of a human drug, including a biological product (herein referred to as drug delivery devices). The guidance describes FDA's recommendations related to the device design outputs that are essential for establishing and assessing drug delivery performance. FDA is providing recommendations for development and organization of device drug-delivery performance information to improve the consistency of this information in applications and submissions. The guidance is intended to facilitate and streamline development of drug delivery devices.
21st Century Cures Act: Establishment of Disincentives for Health Care Providers That Have Committed Information Blocking
This final rule implements the provision of the 21st Century Cures Act specifying that a health care provider determined by the HHS Inspector General to have committed information blocking shall be referred to the appropriate agency to be subject to appropriate disincentives set forth through notice and comment rulemaking. This rulemaking establishes, for certain health care providers, a set of appropriate disincentives using authorities under applicable Federal law.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
